
    
      Primary Objective:

        -  Determine response rate (RR; complete and partial response [CR, PR]) and duration after
           therapy with Aroplatinâ„¢ in patients with advanced solid malignancies.

      Secondary Objective:

        -  Determine the safety and tolerability of Aroplatin
    
  